Clinical trial
Pharmacological Association of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on Blood Pressure and Cardiovascular Risk in Relation to Anti-hypertensive Treatment
NCT00006294 is registered in ClinicalTrials.gov with Donna Arnett, 257-5678 as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacological Association of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on Blood Pressure and Cardiovascular Risk in Relation to Anti-hypertensive Treatment
- Lead sponsor
- Donna Arnett, 257-5678
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 1999
- Completion date
- August 31, 2005
- Enrollment
- 37,939 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.